Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
2378.0 GBX 7.00 ( 0.30%)
Last update at 2026-10-27T16:35:00Z
VOLUME
1445442
Market Cap
27457.57M
P/E
4.16

Momentum Score

…

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2339.00
Low
2383.00
High
52 Week Price Range
2255.00
Low
4446.43
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
2371.00
Dividend Yield
2.97%
Revenue TTM
6620.00M
Revenue Per Share
6.86
Gross Profit TTM
6620.00M
Debt / Equity
0.05
ROE
25.05%
Net Debt
827.00M
ROCE
19.45%
Diluted EPS TTM
6.49

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 5039.00M 3838.00M 4575.00M 4018.00M 1855.00M
Net income 5038.00M 3836.00M 4573.00M 4013.00M 1855.00M
Selling general administrative 32.00M 34.00M 137.00M 127.00M 111.00M
Selling and marketing expenses - 110.00M - - -
Gross profit 5189.00M 3977.00M 4712.00M 4145.00M 1966.00M
Reconciled depreciation 12.00M 8.00M 6.00M 7.00M 7.00M
Ebit 5039.00M 3816.00M 4661.00M 4117.00M 1855.00M
Ebitda 5051.00M 3824.00M 4667.00M 4124.00M 1862.00M
Depreciation and amortization 12.00M 8.00M 6.00M 7.00M 7.00M
Operating income 5039.00M 3824.00M 4661.00M 4117.00M 1855.00M
Other operating expenses 229.00M 153.00M 137.00M 125.00M 111.00M
Interest expense 79.00M 112.00M 92.00M 99.00M 54.00M
Tax provision 1.00M 2.00M 2.00M 5.00M 0.00M
Interest income 73.00M 100.00M 74.00M 83.00M 27.00M
Net interest income -6.00M -12.00M -18.00M -16.00M -27.00M
Income tax expense 1.00M 2.00M 2.00M 5.00M 54.00M
Total revenue 5268.00M 3977.00M 4712.00M 4145.00M 1966.00M
Total operating expenses 150.00M 153.00M 137.00M 127.00M 111.00M
Cost of revenue 79.00M 3465.00M - - -
Total other income expense net - 14.00M -86.00M -99.00M -54.00M
Net income from continuing ops 5038.00M 3836.00M 4573.00M 4013.00M 1855.00M
Net income applicable to common shares - - - 4012.00M 1855.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 26056.00M 21641.00M 17819.00M 14842.00M 10334.00M
Intangible assets 2.00M 4.00M - - 8.00M
Other current assets - 130.00M - 210.00M 112.00M
Total liab 1445.00M 1471.00M 975.00M 2088.00M 1170.00M
Total stockholder equity 24611.00M 20170.00M 16844.00M 12754.00M 9164.00M
Other current liab -1.00M 66.00M -110.00M -129.00M -79.00M
Common stock 719.00M 719.00M 719.00M 719.00M 719.00M
Capital stock 719.00M 719.00M 719.00M 719.00M 719.00M
Retained earnings - 1519.00M - 1125.00M 916.00M
Other liab - - - 966.00M 98.00M
Other assets - -190.00M 114.00M 210.00M 131.00M
Cash 412.00M 358.00M 162.00M 229.00M 216.00M
Total current liabilities 145.00M 165.00M 110.00M 129.00M 79.00M
Current deferred revenue - -4.00M - - -
Net debt 827.00M 893.00M 623.00M 760.00M 776.00M
Short term debt - 4.00M - - -
Short long term debt total 1239.00M 1251.00M 785.00M 989.00M 992.00M
Other stockholder equity 23892.00M 699.00M 16125.00M 12035.00M 8445.00M
Property plant equipment - - - 16.00M 21.00M
Total current assets 445.00M 537.00M 205.00M 288.00M 233.00M
Long term investments 25409.00M 21041.00M 17483.00M 14322.00M 9941.00M
Net tangible assets - - - 12748.00M 9156.00M
Short term investments - 186.00M - - -
Net receivables 33.00M 49.00M 43.00M 59.00M 17.00M
Long term debt - - - - 975.00M
Accounts payable 145.00M 96.00M 110.00M 129.00M 79.00M
Accumulated other comprehensive income - 17233.00M - - -
Common stock total equity - - - - 719.00M
Non currrent assets other 18497.00M 196.00M -17500.00M -14344.00M -9970.00M
Non current assets total 25611.00M 21294.00M 17500.00M 14344.00M 9970.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -16.00M -3.00M -1.00M 0.00M -1.00M
Change to liabilities - - - 0.00M 0.00M
Total cashflows from investing activities -16.00M -3.00M - - -1.00M
Net borrowings -6.00M 416.00M - -4.00M 390.00M
Total cash from financing activities -690.00M -164.00M -773.00M -498.00M 7.00M
Net income 5038.00M 3836.00M 4573.00M 4013.00M 1855.00M
Change in cash 54.00M 196.00M 183.00M 4.00M -555.00M
Begin period cash flow 358.00M 162.00M 229.00M 225.00M 771.00M
End period cash flow 412.00M 358.00M 412.00M 229.00M 216.00M
Total cash from operating activities 763.00M 366.00M 4573.00M 4020.00M -559.00M
Issuance of capital stock 1.00M 1.00M 1.00M 1.00M 1.00M
Depreciation - 8.00M - 7.00M 7.00M
Dividends paid 625.00M 541.00M 485.00M 389.00M 338.00M
Sale purchase of stock - 0.00M -30.00M -54.00M 1.00M
Other cashflows from financing activities -60.00M -40.00M -54.00M -52.00M 349.00M
Change to netincome - - - -3512.00M -2421.00M
Capital expenditures 16.00M 3.00M 1.00M 0.00M 1.00M
Change in working capital - - - - 39.00M
Stock based compensation - 39.00M - - -
Other non cash items 763.00M -3478.00M -4573.00M -4020.00M -1862.00M
Free cash flow 747.00M 363.00M 4572.00M 4020.00M -560.00M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
III
3I Group PLC
7.00
0.30%
2378.00 4.16 8.35 4.15 0.96 4.41
MNTN
Schiehallion Fund Ltd
-0.01
0.46%
2.18 0.05 - 4.35 1.25 5.65
BHMU
BH Macro Limited
-
-%
4.29 0.09 - 39.01 0.71 6.47
TFG
Tetragon Financial Group Ltd
0.15
1.00%
15.10 0.02 7.04 1.16 0.31 2.06
BPCR
BioPharma Credit PLC
0.00
0.41%
0.98 0.09 - 6.73 0.91 7.95

Profile*

3I Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co

1 Knightsbridge, London, United Kingdom, SW1X 7LX

44 20 7975 3131

223

Name Title Year Born
Mr. Simon A. Borrows CEO & Exec. Director 1959
Mr. James Graham Hatchley Group Fin. Director & Director 1967
Ms. Jasi Halai Group Financial Controller, COO & Director 1978
Ms. Silvia Santoro Director of Investor Relations NA
Mr. Kevin J. Dunn Gen. Counsel & Company Sec. 1963
Ms. Kathryn van der Kroft Director of Communications NA
Mr. Julien Marie Chief HR Officer NA
Mr. Alastair Richardson Director & Head of Legal - Private Equity NA
Mr. Tony Lissaman Chief Operating Officer of Private Equity NA
Mr. Jonathan Crane Partner & Head of Industrial NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…